Research location
Wuhu
Anhui, China
Advertisement
Research activity in Wuhu
Anhui, ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 36 trials and 36 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Wuhu
36 linked trials · page 1 of 1Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLDNCT07632677 · 2026-05-15 · 1 site observation
RECRUITING
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.NCT07028853 · 2025-09-28 · 1 site observation
RECRUITING
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast CancerNCT07043725 · 2025-09-15 · 1 site observation
RECRUITING
Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive DisorderNCT06692361 · 2025-01-01 · 1 site observation
RECRUITING
The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate CancerNCT06737588 · 2024-12-01 · 1 site observation
RECRUITING
The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast CancerNCT06452706 · 2024-11-14 · 1 site observation
RECRUITING
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.NCT06629779 · 2024-10-22 · 1 site observation
RECRUITING
Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid TumorsNCT06126406 · 2023-11-06 · 1 site observation
RECRUITING
China Health Big DataNCT03699228 · 2017-12-01 · 1 site observation
RECRUITING
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion Ratio in Patients With Acute Respiratory FailureNCT07603037 · 2026-07-15 · 1 site observation
NOT_YET_RECRUITING
Effects of Exercise Sequence and Meal Sequence on Weight Management Among Children and Adolescents With Overweight or Obesity: The STEP TrialNCT07712068 · 2026-07-01 · 1 site observation
NOT_YET_RECRUITING
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid TumorsNCT07160335 · 2025-09-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation the Safety of hemay005 TabletsNCT06908642 · 2024-12-25 · 1 site observation
COMPLETED
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).NCT06606509 · 2024-11-07 · 1 site observation
NOT_YET_RECRUITING
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).NCT06551324 · 2024-10-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive DisorderNCT07253207 · 2024-10-17 · 1 site observation
COMPLETED
A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung CancerNCT05990127 · 2023-11-14 · 1 site observation
NOT_YET_RECRUITING
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 InhibitorNCT06109311 · 2023-11-10 · 1 site observation
COMPLETED
A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise AloneNCT05971940 · 2023-08-09 · 1 site observation
COMPLETED
A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 SchizophreniaNCT05919823 · 2023-05-29 · 1 site observation
COMPLETED
YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion MutationsNCT05767892 · 2023-05-01 · 1 site observation
NOT_YET_RECRUITING
Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung CancerNCT05577702 · 2023-03-08 · 1 site observation
COMPLETED
A Study of LY3484356 in Chinese Participants With Advanced Breast CancerNCT05509790 · 2022-10-09 · 1 site observation
ACTIVE_NOT_RECRUITING
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast CancerNCT05365178 · 2022-07-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Effects of Buspirone Combined With ClozapineNCT06906224 · 2022-05-01 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast CancerNCT05346224 · 2022-04-25 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)NCT05288166 · 2022-04-14 · 1 site observation
ACTIVE_NOT_RECRUITING
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsNCT05253053 · 2022-04-13 · 1 site observation
COMPLETED
A Food-drug Interaction Study of SY-004 in Healthy SubjectsNCT04907006 · 2021-08-31 · 1 site observation
COMPLETED
Chiglitazar Added to Metformin for Type 2 DiabetesNCT04807348 · 2021-07-06 · 1 site observation
COMPLETED
A Drug Interaction Study of SY-004 Capsules in Healthy SubjectsNCT04907019 · 2021-07-06 · 1 site observation
COMPLETED
A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3NCT06507462 · 2021-01-01 · 1 site observation
COMPLETED
Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 DiabetesNCT04373967 · 2020-04-29 · 1 site observation
UNKNOWN
A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung CancerNCT04439890 · 2019-08-08 · 1 site observation
UNKNOWN
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate CancerNCT03706365 · 2018-11-26 · 1 site observation
ACTIVE_NOT_RECRUITING
A Clinical Study of Xin'an Medicine in the Treatment of Bi SyndromeNCT01774877 · 2013-07-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.